Monday, June 15, 2026

How Celltrion’s Omlyclo is Dominating Spain’s Omalizumab Market: A First-Mover Success Story

Celltrion's Omlyclo treatment is thriving in Spain, capturing over 60% of the omalizumab market with innovative strategies and strong demand.

Tag: Kim Myung Soo

No posts to display

Top News

- Our Sponsors Ad -

Follow us